Sensible Diagnostics Gets $1M NIH RADx Award for COVID Test Development
Sensible Diagnostics was selected by the RADx Tech program launched by the NIBIB, which is part of the National Institutes of Health (NIH).
Read MorePosted by Andy Lundin | Aug 21, 2023 | Covid 19 |
Sensible Diagnostics was selected by the RADx Tech program launched by the NIBIB, which is part of the National Institutes of Health (NIH).
Read MorePosted by Andy Lundin | Aug 21, 2023 | Melanoma |
This skin cancer monitoring approach integrates a minimally invasive microneedle platform with a sensitive, single-molecule detection method.
Read MorePosted by Andy Lundin | Aug 17, 2023 | Emerging & Zoonotic Diseases |
Current diagnostic methods can vastly overestimate the rates that malaria parasites are multiplying in an infected person’s blood.
Read MorePosted by Andy Lundin | Aug 16, 2023 | Company News |
HealthTrackRx has been presented with the One Southern Indiana “Economic Development Impact Project of the Year” award.
Read MorePosted by Andy Lundin | Aug 10, 2023 | Lab Automation, Microscopy |
A team of researchers assessed whether a fully automated system utilizing AI can accurately diagnose malaria.
Read More